Kazusamycin B

Kazusamycin B

CAT N°: 28119
Price:

From 641.00 544.85

Kazusamycin B is a bacterial metabolite originally isolated from Streptomyces.{47374} It has antifungal activity against S. pombe and R. javanicus (MICs = 0.05 and 2.13 µg/ml, respectively) but is inactive against Gram-positive and Gram-negative bacteria (MICs = >100 µg/ml). Kazusamycin B (5 ng/ml) halts the cell cycle at the G1 phase and induces nuclear condensation in L1210 cells, as well as inhibits nuclear-to-cytosolic transport of the HIV-1 regulatory protein Rev in HeLa cells expressing Rev (IC50 = 6.3 nM).{47375,31690} It is cytotoxic to L1210 and HCT-8 cells with IC50 values of 1.8 and 1.6 ng/ml, respectively, and reduces tumor growth in a variety of murine tumor and mouse xenograft models.{47376}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • (2E,10E,12E,16Z,18E)-19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-6-hydroxy-9-(hydroxymethyl)-3,5,7,11,15,17-hexamethyl-8-oxo-2,10,12,16,18-nonadecapentaenoic acid
  • Correlated keywords
    • 734501-02-1 anti-fungal biotic Schizosaccharomyces G 1 L 1210 HIV1 He La HCT8 cyto-toxic PD124895 Hydroxy-leptomycin CL1957E 1957 E
  • Product Overview:
    Kazusamycin B is a bacterial metabolite originally isolated from Streptomyces.{47374} It has antifungal activity against S. pombe and R. javanicus (MICs = 0.05 and 2.13 µg/ml, respectively) but is inactive against Gram-positive and Gram-negative bacteria (MICs = >100 µg/ml). Kazusamycin B (5 ng/ml) halts the cell cycle at the G1 phase and induces nuclear condensation in L1210 cells, as well as inhibits nuclear-to-cytosolic transport of the HIV-1 regulatory protein Rev in HeLa cells expressing Rev (IC50 = 6.3 nM).{47375,31690} It is cytotoxic to L1210 and HCT-8 cells with IC50 values of 1.8 and 1.6 ng/ml, respectively, and reduces tumor growth in a variety of murine tumor and mouse xenograft models.{47376}

We also advise you